Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Large Cap Fund median (35 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 26 May 2008 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 100 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | ICICI Prudential Large Cap Fund |
|---|---|
| 26 May 2008 | ₹100.00 |
| 02 Dec 2009 | ₹134.53 |
| 10 Jun 2011 | ₹161.98 |
| 16 Dec 2012 | ₹183.73 |
| 24 Jun 2014 | ₹250.60 |
| 31 Dec 2015 | ₹285.13 |
| 08 Jul 2017 | ₹361.28 |
| 14 Jan 2019 | ₹400.30 |
| 22 Jul 2020 | ₹406.49 |
| 28 Jan 2022 | ₹649.30 |
| 06 Aug 2023 | ₹768.96 |
| 11 Feb 2025 | ₹1002.79 |
| 20 Aug 2026 | ₹1091.32 |
| Metric | ICICI Prudential · Regular NAV ₹109.35 Very High risk ★★★★★ | Category median Large Cap Fund · 35 funds |
|---|---|---|
| -1.85% | -0.15% | |
| +12.54% | +11.26% | |
| +12.60% | +9.97% | |
| +13.12% | +11.47% | |
| +14.00% | +11.40% | |
| +10.55% | — | |
| +15.37% | +13.21% | |
| +15.12% | +12.15% | |
| +14.34% | +12.34% | |
| Risk | ||
| 12.56% | 13.29% | |
| 0.48 | 0.34 | |
| 0.67 | 0.47 | |
| -39.94% | -36.99% | |
| Nifty 100 | — | |
| +2.60% | +1.29% | |
| 0.90 | 0.96 | |
| 101.9% | 101.0% | |
| 86.5% | 93.9% | |
| 1.50% | 2.19% | |
| ₹76,534Cr | ₹2,004Cr | |
| 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 51% | 44% | |
| Vaibhav Dusad · 5.6y | — | |
| 26 May 2008 | — | |
| 83 | — | |
| 47.9% | — | |
| 4.5% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.